Atlas Trials

Medanta, The Medicity, India

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Medanta, The Medicity, India

RecordFirmDate
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes (NCT06289387)Medanta, The Medicity, India2024-01-20
Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia (NCT06187285)Medanta, The Medicity, India2024-01-01
Empagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus (NCT06098625)Medanta, The Medicity, India2023-11-10
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus (NCT06095492)Medanta, The Medicity, India2023-10-30
Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes (NCT06035874)Medanta, The Medicity, India2023-10-15
To Assess the Prevalence, Management Practices, and Clinical Outcomes Associated With Hyperglycemia Among Hospitalized Patients, With a Particular Focus on the Interplay Between Metabolic Biomarkers, Nutritional Status, and Body Composition (NCT07626775)Medanta, The Medicity, India2023-01-01
Degludec Glargine U300 Hospital Study (NCT05036876)Medanta, The Medicity, India2021-10-10
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NCT03590626)Medanta, The Medicity, India2019-01-01

Track Medanta, The Medicity, India automatically

Every clearance here is in the API, with alerts when new ones post.